Soleno Therapeutics Inc
Board Member
2025-10-13–present
Mark W. Hahn
Board Member
Soleno Therapeutics Inc
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mark W. Hahn
Mark W. Hahn is recorded as Board Member at Soleno Therapeutics Inc. Soleno Therapeutics Inc reported in an 8-K filed May 18, 2026 that Mark W. Hahn resigned as member of the Company's board of directors, effective May 18, 2026. Soleno Therapeutics Inc reported in an 8-K filed October 14, 2025 that Mark W. Hahn was appointed Class II director, effective October 13, 2025.
“each of Anish Bhatnagar, M.D., Mark Hahn, Matthew Pauls, Birgitte Volck, Andrew Sinclair and Dawn Bir resigned from his or her respective positions as a member of the Company's board of directors and all committees thereof effective as of the Effective Time.”
“On October 13, 2025, the Board of Directors (the "Board") of Soleno Therapeutics, Inc. (the "Company") increased the size of its Board and the Audit Committee of its Board (the "Audit Committee") by one member and appointed Mark W. Hahn to the Board and to the Audit Committee.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Soleno Therapeutics Inc
Board Member
SEC 8-K
Current2025-10-13–present
-
Soleno Therapeutics Inc
Board Member
SEC 8-K
2025-10-13–2026-05-18
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.